The DOI matches its Crossref record; 216 of the 216 references it cites were found in a registry or an index.
Cognitive decline in Parkinson disease
Open accessAbstract
Dementia is a frequent problem encountered in advanced stages of Parkinson disease (PD). In recent years, research has focused on the pre-dementia stages of cognitive impairment in PD, including mild cognitive impairment (MCI). Several longitudinal studies have shown that MCI is a harbinger of dementia in PD, although the course is variable, and stabilization of cognition - or even reversal to normal cognition - is not uncommon. In addition to limbic and cortical spread of Lewy pathology, several other mechanisms are likely to contribute to cognitive decline in PD, and a variety of biomarker studies, some using novel structural and functional imaging techniques, have documented in vivo brain changes associated with cognitive impairment. The evidence consistently suggests that low cerebrospinal fluid levels of amyloid-β 42, a marker of comorbid Alzheimer disease (AD), predict future cognitive decline and dementia in PD. Emerging genetic evidence indicates that in addition to the APOE*ε4 allele (an established risk factor for AD), GBA mutations and SCNA mutations and triplications are associated with cognitive decline in PD, whereas the findings are mixed for MAPT polymorphisms. Cognitive enhancing medications have some effect in PD dementia, but no convincing evidence that progression from MCI to dementia can be delayed or prevented is available, although cognitive training has shown promising results.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Moreover there are several candidate genetic risk factors that overlap for AD and PD, most notably APOE and MAPT [127].”
From The neuropathological diagnosis of Alzheimer's disease (2019) · cites this paper as [127]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Staging of brain pathology related to sporadic Parkinson’s disease
Braak, H., Tredici, K. D., Rüb, U., de Vos, R. A. I., Jansen Steur, E. N. H., & Braak, E. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00065-9 · Cited by 10,777
MDS clinical diagnostic criteria for Parkinson’s disease
Postuma, R. B., Berg, D., Stern, M., Poewe, W., Olanow, C. W., Oertel, W., Obeso, J., Marek, K., Litvan, I., Lang, A. E., et al. (2015) · Movement Disorders · doi:10.1002/mds.26424 · Cited by 7,653
Terry, R. D., Masliah, E., Salmon, D. P., Butters, N., DeTeresa, R., Hill, R., Hansen, L. A., & Katzman, R. (1991) · Annals of Neurology · doi:10.1002/ana.410300410 · Cited by 4,397
Clinical diagnostic criteria for dementia associated with Parkinson’s disease
Emre, M., Aarsland, D., Brown, R., Burn, D. J., Duyckaerts, C., Mizuno, Y., Broe, G. A., Cummings, J., Dickson, D. W., Gauthier, S., et al. (2007) · Movement Disorders · doi:10.1002/mds.21507 · Cited by 3,027
Self-citationLitvan, I., Goldman, J. G., Tröster, A. I., Schmand, B. A., Weintraub, D., Petersen, R. C., Mollenhauer, B., Adler, C. H., Marder, K., Williams‐Gray, C. H., et al. (2012) · Movement Disorders · doi:10.1002/mds.24893 · Cited by 2,609
Self-citationThe Sydney multicenter study of Parkinson's disease: The inevitability of dementia at 20 years
Hely, M. A., Reid, W. G. J., ADENA, M. A., Halliday, G. M., & Morris, J. G. (2008) · Movement Disorders · doi:10.1002/mds.21956 · Cited by 2,346
α-synuclein locus duplication as a cause of familial Parkinson's disease
Chartier-Harlin, M.-C., Kachergus, J., Roumier, C., Mouroux, V., Douay, X., Lincoln, S., Levecque, C., Larvor, L., Andrieux, J., Hulihan, M., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17103-1 · Cited by 2,029
Healy, D. G., Falchi, M., O'Sullivan, S. S., Bonifati, V., Durr, A., Bressman, S., Brice, A., Aasly, J., Zabetian, C. P., Goldwurm, S., et al. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(08)70117-0 · Cited by 1,425
Prevalence and Characteristics of Dementia in Parkinson Disease
Aarsland, D., Andersen, K., Larsen, J. O., & Lolk, A. (2003) · Archives of Neurology · doi:10.1001/archneur.60.3.387 · Cited by 1,403
Self-citationMultimodal classification of Alzheimer's disease and mild cognitive impairment
Zhang, D., Wang, Y., Zhou, L., Yuan, H., & Shen, D. G. (2011) · NeuroImage · doi:10.1016/j.neuroimage.2011.01.008 · Cited by 1,340
Cited by
Sorted by citations
Items 301–400 of 1,000
Bezdíček, O., Červenková, M., Moore, T. M., Georgi, H. S., Šulc, Z., Wolk, D. A., Weintraub, D. A., Moberg, P. J., Jech, R., Kopeček, M., et al. (2018) · Assessment · doi:10.1177/1073191118778896 · Cited by 24
Self-citationHu, H., Chen, J., Huang, H., Zhou, C.-H., Zhang, S., Liu, X., Wang, L., Chen, P., Nie, K., Chen, L., et al. (2019) · Brain Imaging and Behavior · doi:10.1007/s11682-018-0031-x · Cited by 23
Tzvetkov, N. T., Stammler, H., Georgieva, M. G., Russo, D., Faraone, I., Balacheva, A. A., Hristova, S., Atanasov, A. G., Milella, L., Antonov, L., et al. (2019) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2019.06.041 · Cited by 24
Salivary biomarkers: The early diagnosis of Alzheimer's disease
Nazir, S. (2024) · Aging Medicine · doi:10.1002/agm2.12282 · Cited by 26
Neutrophil‐to‐lymphocyte ratio and longitudinal cognitive performance in Parkinson's disease
Lucero, J., Gurnani, A. S., Weinberg, J., & Shih, L. C. (2024) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.52144 · Cited by 23
Air pollution: a latent key driving force of dementia
Mohammadzadeh, M., Khoshakhlagh, A. H., & Grafman, J. H. (2024) · BMC Public Health · doi:10.1186/s12889-024-19918-4 · Cited by 26
Metabolomics in Parkinson’s Disease and Correlation with Disease State
Ostrakhovitch, E. A., Ono, K., & Yamasaki, T. R. (2025) · Metabolites · doi:10.3390/metabo15030208 · Cited by 24
Revamping Parkinson’s disease therapy using PLGA-based drug delivery systems
Lababidi, J. M., & Azzazy, H. M. E.-S. (2025) · npj Parkinson s Disease · doi:10.1038/s41531-025-01081-1 · Cited by 27
Kim, I., Shin, N., Bak, Y., Lee, P. H., Lee, S., & Lim, S. M. (2017) · Scientific Reports · doi:10.1038/s41598-017-02420-w · Cited by 23
Clinical Ethics in the Context of Deep Brain Stimulation for Movement Disorders
Kubu, C. S., & Ford, P. J. (2017) · Archives of Clinical Neuropsychology · doi:10.1093/arclin/acx088 · Cited by 23
Wang, Z., Lin, Y., Liu, W., Kuang, P., Lao, W., Ji, Y., & Zhu, H. (2019) · Neuroscience · doi:10.1016/j.neuroscience.2019.08.024 · Cited by 23
Sharma, A., Muresanu, D. F., Nozari, A., Lafuente, J. V., Sahib, S., Tian, Z. R., Buzoianu, A. D., Patnaik, R., Wiklund, L., & Sharma, H. S. (2020) · Progress in brain research · doi:10.1016/bs.pbr.2020.09.010 · Cited by 23
Brain connectivity markers in advanced Parkinson’s disease for predicting mild cognitive impairment
Lin, H., Liu, Z., Yan, W. P., Zhang, D., Liu, J., Xu, B., Li, W., Zhang, Q., & Cai, X. (2021) · European Radiology · doi:10.1007/s00330-021-08086-3 · Cited by 23
Koros, C., Stefanis, L., & Scarmeas, N. (2021) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2021.120015 · Cited by 26
Rezazadeh‐Shojaee, F., Ramazani, E., Kasaian, J., & Tayarani‐Najaran, Z. (2021) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.22956 · Cited by 24
Freezing of gait is a risk factor for cognitive decline in Parkinson’s disease
Qu, Y., Li, J., Chen, Y., Li, J., Qin, Q., Wang, D., Zhao, J., Yang, Q., Mao, Z., Xiong, Y., et al. (2022) · Journal of Neurology · doi:10.1007/s00415-022-11371-w · Cited by 23
Goffredo, M., Pagliari, C., Turolla, A., Tassorelli, C., Tella, S. D., Federico, S., Pournajaf, S., Jonsdottir, J., Icco, R. D., Pellicciari, L., et al. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12093178 · Cited by 26
Race and Ethnicity in Lewy Body Dementia: A Narrative Review
Bayram, E., Holden, S. K., Fullard, M. E., & Armstrong, M. J. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-230207 · Cited by 24
A multiple hits hypothesis for memory dysfunction in Parkinson disease
Citro, S., Lazzaro, G. D., Cimmino, A. T., Giuffrè, G. M., Marra, C., & Calabresi, P. (2023) · Nature Reviews Neurology · doi:10.1038/s41582-023-00905-z · Cited by 23
Mishra, V. R., Sreenivasan, K. R., Zhuang, X., Yang, Z., Cordes, D., & Walsh, R. R. (2019) · Heliyon · doi:10.1016/j.heliyon.2019.e01481 · Cited by 23
Network Connectivity Determines Cortical Thinning In Early Parkinson’s Disease ProgressionPreprint
Yau, Y., Zeighami, Y., Baker, T. E., Larcher, K., Vainik, U., Dadar, M., Fonov, V., Hagmann, P., Griffa, A., Mišić, B., et al. (2017) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/147611 · Cited by 24
Bosch‐Barceló, P., Masbernat, M. A., Martínez-Navarro, O., Tersa-Miralles, C., Pakarinen, A., & Fernández‐Lago, H. (2024) · Journal of NeuroEngineering and Rehabilitation · doi:10.1186/s12984-024-01399-6 · Cited by 22
Epigenetic regulation in the pathophysiology of Lewy body dementia
Chouliaras, L., Kumar, G. S., Thomas, A. J., Lunnon, K., Chinnery, P. F., & O'Brien, J. T. (2020) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2020.101822 · Cited by 24
Dietary intake and plasma levels of polyunsaturated fatty acids in early-stage Parkinson’s disease
Yoo, D., Lim, Y., Son, Y., Rho, H., Shin, C., & Ahn, T. (2021) · Scientific Reports · doi:10.1038/s41598-021-92029-x · Cited by 22
Chua, L.-K., Chung, Y., Bellard, D., Swan, L., Gobreial, N., Romano, A., Glatt, R. M., Bonaguidi, M. A., Lee, D. J., Jin, Y., et al. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph182312384 · Cited by 22
Mild Cognitive Impairment Subtypes Are Associated With Peculiar Gait Patterns in Parkinson’s Disease
Amboni, M., Ricciardi, C., Cuoco, S., Donisi, L., Volzone, A., Ricciardelli, G., Pellecchia, M. T., Santangelo, G., Cesarelli, M., & Barone, P. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.781480 · Cited by 22
Chan, L., Chung, C., Hsieh, Y., Wu, R., & Hong, C. (2023) · Therapeutic Advances in Neurological Disorders · doi:10.1177/17562864221150329 · Cited by 22
Shantaraman, A., Dammer, E. B., Ugochukwu, O., Duong, D. M., Yin, L., Carter, E. K., Gearing, M., Chen‐Plotkin, A. S., Lee, E. B., Trojanowski, J. Q., et al. (2024) · Molecular Neurodegeneration · doi:10.1186/s13024-024-00749-1 · Cited by 23
Cheon, S. Y., & Cho, K. (2019) · Journal of Molecular Medicine · doi:10.1007/s00109-018-01739-9 · Cited by 22
Masih, A., Singh, S., Agnihotri, A. K., Giri, S., Shrivastava, J. K., Pandey, N., Bhat, H. R., & Singh, U. P. (2020) · Neuroscience Letters · doi:10.1016/j.neulet.2020.135222 · Cited by 22
Mazancová, A. F., Růžička, E., Jech, R., & Bezdíček, O. (2020) · Archives of Clinical Neuropsychology · doi:10.1093/arclin/acaa039 · Cited by 22
Patterns of diffusion kurtosis changes in Parkinson's disease subtypes
Minsterová, A. Š., Klobušiaková, P., Pies, A., Galáž, Z., Mekyska, J., Novakova, L., Elfmarková, N., & Rektorová, I. (2020) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2020.10.032 · Cited by 22
“Pseudo-syndromes” associated with Parkinson disease, dementia, apathy, anxiety, and depression
Weiss, H. D., & Pontone, G. M. (2019) · Neurology Clinical Practice · doi:10.1212/cpj.0000000000000644 · Cited by 21
Srivastava, G., & Ganjewala, D. (2024) · Phytomedicine Plus · doi:10.1016/j.phyplu.2024.100532 · Cited by 26
Non-motor symptoms of Parkinson`s disease-insights from genetics
Gotovac, K., Blažeković, A., Borovečki, S., & Borovečki, F. (2024) · Journal of Neural Transmission · doi:10.1007/s00702-024-02833-8 · Cited by 21
Liebert, A. D., Bicknell, B. T., Laakso, E., Tilley, S., Heller, G. Z., Kiat, H., & Herkes, G. (2024) · BMC Neurology · doi:10.1186/s12883-024-03857-z · Cited by 21
Hölscher, C. (2025) · CNS Drugs · doi:10.1007/s40263-025-01226-z · Cited by 26
Souza, M. F. D. S., Bacha, J. M. R., da Silva, K. G., de Freitas, T. B., Torriani‐Pasin, C., & Pompeu, J. E. (2018) · Fisioterapia em Movimento · doi:10.1590/1980-5918.031.ao12 · Cited by 21
Chang, Z., Xie, F., Li, H., Yuan, F., Zeng, L., Shi, L., Zhu, S., Lu, X., Wei, X., & Wang, Q. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.832768 · Cited by 21
Wu, Y., Rakotoarisoa, M., Angelov, B., Deng, Y., & Angelova, A. (2022) · Nanomaterials · doi:10.3390/nano12132267 · Cited by 21
Wang, J., Zhang, W., Zhou, Y., Jia, J., Li, Y., Liu, K., Ye, Z., & Jin, L. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.896191 · Cited by 21
Huang, S., Su, Z.-Y., Han, Y., Liu, L., Shang, Y., Mai, Z.-F., Zeng, Z.-W., & Li, C. (2023) · Phytomedicine · doi:10.1016/j.phymed.2023.154649 · Cited by 21
MPTAC Determines APP Fragmentation via Sensing Sulfur Amino Acid Catabolism
Suganuma, T., Swanson, S. K., Gogol, M., Garrett, T. J., Conkright-Fincham, J., Florens, L. A., Washburn, M. P., & Workman, J. L. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.07.013 · Cited by 21
Enache, D., Pereira, J. B., Jelić, V., Winblad, B. G., Nilsson, P., Aarsland, D., & Bereczki, E. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-200498 · Cited by 23
Self-citationNucleus basalis of Meynert degeneration predicts cognitive impairment in Parkinson's disease
Wilson, H., de Natale, E. R., & Politis, M. (2021) · Handbook of clinical neurology · doi:10.1016/b978-0-12-819975-6.00010-8 · Cited by 21
Self-citationIbáñez, L., Bahena, J. A., Yang, C., Dube, U., Farias, F., Budde, J., Bergmann, K., Brenner-Webster, C., Morris, J. C., Perrin, R. J., et al. (2020) · Acta Neuropathologica Communications · doi:10.1186/s40478-020-01072-8 · Cited by 20
Lennon, J. C., & Hassan, I. (2021) · Neurological Sciences · doi:10.1007/s10072-020-05020-1 · Cited by 20
Dual-task intervention based on trail making test: Effects on Parkinson's disease
Silva, R. D. N., Afonso, S. V., Felipe, L. R. R., Oliveira, R. D. A., Patrizzi, L. J., & de Souza, L. A. P. S. (2021) · Journal of Bodywork and Movement Therapies · doi:10.1016/j.jbmt.2021.04.013 · Cited by 20
Jonkman, L. E., Fathy, Y. Y., Berendse, H. W., Schoonheim, M. M., & van de Berg, W. D. J. (2021) · Scientific Reports · doi:10.1038/s41598-021-95638-8 · Cited by 21
Rong, S., Zhang, P., He, C., Li, Y., Li, X., Li, R., Nie, K., Huang, S.-F., Wang, L., Wang, L., et al. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.709998 · Cited by 20
Current Therapies and Drug Development Pipeline in Lewy Body Dementia: An Update
MacDonald, S., Shah, A. S., & Tousi, B. (2022) · Drugs & Aging · doi:10.1007/s40266-022-00939-w · Cited by 20
Huang, R., Gao, Y., Duan, Q., Zhang, Q., He, P., Chen, J., Ma, G., Wang, L., Zhang, Y., Nie, K., et al. (2022) · Molecular Neurobiology · doi:10.1007/s12035-022-03119-4 · Cited by 20
Simone, M. D. D., Costa, A., Tieri, G., Taglieri, S., Cona, G., Fiorenzato, E., Carlesimo, G., Caltagirone, C., & Zabberoni, S. (2023) · Frontiers in Psychology · doi:10.3389/fpsyg.2023.1268337 · Cited by 17
Parkinson’s disease: what the model systems have taught us so far
Ghatak, S., Trudler, D., Dolatabadi, N., & Ambasudhan, R. (2018) · Journal of Genetics · doi:10.1007/s12041-018-0960-6 · Cited by 20
SNCA Rep1 promoter variability influences cognition in Parkinson's disease
Ng, A. S. L., Tan, Y. J., Zhao, Y., Saffari, S. E., Lu, Z., Ng, E., Ng, S. Y., Chia, N. S. Y., Setiawan, F., Xu, Z., et al. (2019) · Movement Disorders · doi:10.1002/mds.27768 · Cited by 20
A quick test of cognitive speed can predict development of dementia in Parkinson’s disease
Jalakas, M., Palmqvist, S., Hall, S., Svärd, D., Lindberg, O. E., Pereira, J. B., van Westen, D., & Hansson, O. (2019) · Scientific Reports · doi:10.1038/s41598-019-51505-1 · Cited by 19
Trošt, M., Perovnik, M., & Pirtošek, Z. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.01204 · Cited by 20
Yoo, H. S., Chung, S. J., Lee, Y. H., Ye, B. S., Sohn, Y. H., & Lee, P. H. (2020) · European Journal of Neurology · doi:10.1111/ene.14188 · Cited by 20
Zhang, C., Wu, C., Zhang, H., Dou, W., Li, W., Sami, M. U., & Xu, K. (2020) · Neuroscience · doi:10.1016/j.neuroscience.2020.07.008 · Cited by 22
Clinical Characterization of Parkinson's Disease Patients With Cognitive Impairment
Gozalbo, A. S., Rodríguez‐Blázquez, C., Forjaz, M. J., & Martínez‐Martín, P. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.00731 · Cited by 23
Cognitive effects of rhythmic auditory stimulation in Parkinson’s disease: A P300 study
Lei, J., Conradi, N., Abel, C., Frisch, S., Brodski‐Guerniero, A., Hildner, M., Kell, C. A., Kaiser, J., & Schmidt‐Kassow, M. (2018) · Brain Research · doi:10.1016/j.brainres.2018.05.016 · Cited by 20
Yedlapudi, D., Xu, L., Luo, D., Marsh, G. B., Todi, S. V., & Dutta, A. K. (2019) · Scientific Reports · doi:10.1038/s41598-019-55830-3 · Cited by 20
Les symptômes non-moteurs de la maladie de Parkinson de la physiopathologie au diagnostic précoce
Aubignat, M., Tir, M., & Krystkowiak, P. C. (2020) · La Revue de Médecine Interne · doi:10.1016/j.revmed.2020.06.019 · Cited by 26
Vitório, R. R., Stuart, S., Giritharan, A. B., Quinn, J. F., Nutt, J. G., & Mancini, M. (2021) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2021.03.014 · Cited by 19
Brain functional specialization and cooperation in Parkinson’s disease
Sun, J., Gao, X., Hua, Q., Du, R., Liu, P., Liu, T., Yang, J., Qiu, B., Ji, G., Hu, P., et al. (2021) · Brain Imaging and Behavior · doi:10.1007/s11682-021-00526-4 · Cited by 19
Stratification Tools for Disease‐Modifying Trials in Prodromal Synucleinopathy
Arnaldi, D., Mattioli, P., Famà, F., Girtler, N. G., Brugnolo, A., Pardini, M., Donniaquio, A., Massa, F., Orso, B., Raffa, S., et al. (2021) · Movement Disorders · doi:10.1002/mds.28785 · Cited by 19
Insect Models in Nutrition Research
Tonk, M., Vilcinskas, A., & Wagner, A. E. (2022) · Biomolecules · doi:10.3390/biom12111668 · Cited by 19
Targeting G Protein-Coupled Receptors in the Treatment of Parkinson's Disease.
Jones-Tabah, J. (2022) · Journal of Molecular Biology · doi:10.1016/j.jmb.2022.167927 · Cited by 18
Formica, C., Bonanno, L., Latella, D., Ferrera, M. C., Maresca, G., Logiudice, A. L., Sorbera, C., Brigandì, A., Lorenzo, G. D., & Marino, S. (2023) · Scientific Reports · doi:10.1038/s41598-023-29299-0 · Cited by 19
Structural connectivity from DTI to predict mild cognitive impairment in de novo Parkinson’s disease
Huang, X., He, Q., Ruan, X., Li, Y., Kuang, Z., Wang, M., Guo, R., Bu, S., Wang, Z., Yu, S., et al. (2023) · NeuroImage Clinical · doi:10.1016/j.nicl.2023.103548 · Cited by 19
Apolipoprotein E Gene in α-Synucleinopathies: A Narrative Review
Liampas, I., Kyriakoulopoulou, P., Siokas, V., Tsiamaki, E., Stamati, P., Kefalopoulou, Z. M., Chroni, E., & Dardiotis, E. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25031795 · Cited by 30
Associations of Microbiota and Nutrition with Cognitive Impairment in Diseases
Młynarska, E., Jakubowska, P., Frąk, W., Gajewska, A., Sornowska, J., Skwira, S., Wasiak, J., Rysz, J., & Franczyk, B. (2024) · Nutrients · doi:10.3390/nu16203570 · Cited by 19
Shi, X., Zhang, Y., Xu, S., Kung, H. F., Qiao, H., Jiang, L., Zhu, L., Guo, Q., Yi, C., Luo, G., et al. (2019) · Clinical Nuclear Medicine · doi:10.1097/rlu.0000000000002664 · Cited by 19
Church, M. C., Workman, J. L., & Suganuma, T. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221910274 · Cited by 19
Watanabe, H., Shima, S., Kawabata, K., Mizutani, Y., Ueda, A., & Ito, M. (2025) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2024.1507033 · Cited by 19
Schejter‐Margalit, T., Kizony, R., Shirvan, J. C., Cedarbaum, J. M., Bregman, N., Thaler, A., Giladi, N., & Mirelman, A. (2021) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2021.08.002 · Cited by 18
Pan, C., Ren, J., Hua, P., Yan, L., Yu, M., Wang, Y., Zhou, G., Zhang, R., Chen, J., & Liu, W. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.761817 · Cited by 18
Cognitive task-related oscillations in human internal globus pallidus and subthalamic nucleus
Navid, M. S., Kammermeier, S., Niazi, I. K., Sharma, V. D., Vuong, S. M., Bötzel, K., Greenlee, J. D. W., & Singh, A. (2022) · Behavioural Brain Research · doi:10.1016/j.bbr.2022.113787 · Cited by 18
Baba, T., Takeda, A., Murakami, A., Koga, T., Isomura, T., Mori, E., Hisanaga, K., Ugawa, Y., Hattori, N., Murata, M., et al. (2022) · EClinicalMedicine · doi:10.1016/j.eclinm.2022.101571 · Cited by 18
Clinical trials for cognition in Parkinson's disease: Where are we and how can we do better?
Bayram, E., Batzu, L., Tilley, B. S., Gandhi, R., Jagota, P., Biundo, R., Garon, M., Prasertpan, T., Lazcano‐Ocampo, C., Chaudhuri, К. R., et al. (2023) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2023.105385 · Cited by 18
Pomegranate Polyphenol-Derived Injectable Therapeutic Hydrogels to Enhance Neuronal Regeneration
Ju, J., Kim, S., & Shin, M. (2023) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.3c00623 · Cited by 18
Zhu, F., Wang, B.-D., Qin, D., Su, X., Yu, L., Wu, J., Law, B. Y. K., Guo, M., Yu, C., Zhou, X., et al. (2023) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.14515 · Cited by 18
Lomme, J., Reedijk, M., Peters, S., Downward, G. S., Stefanopoulou, M., Vermeulen, R. C. H., & Huss, A. (2023) · Environmental Epidemiology · doi:10.1097/ee9.0000000000000272 · Cited by 18
Imaging the Nonmotor Symptoms in Parkinson's Disease
Yousaf, T., Wilson, H., & Politis, M. (2017) · International review of neurobiology · doi:10.1016/bs.irn.2017.05.001 · Cited by 18
Self-citationBiundo, R., Fiorenzato, E., & Antonini, A. (2017) · International review of neurobiology · doi:10.1016/bs.irn.2017.05.031 · Cited by 18
Lifespan trajectory of affect in Cornelia de Lange syndrome: towards a neurobiological hypothesis
Groves, L., Moss, J. F., Crawford, H., Nelson, L., Stinton, C., Singla, G., & Oliver, C. (2019) · Journal of Neurodevelopmental Disorders · doi:10.1186/s11689-019-9269-x · Cited by 18
Maynard, M. E., Redell, J. B., Kobori, N., Underwood, E. L., Fischer, T. D., Hood, K. N., LaRoche, V., Waxham, M. N., Moore, A. N., & Dash, P. K. (2019) · Experimental Neurology · doi:10.1016/j.expneurol.2019.113081 · Cited by 18
Sánchez-Dinorín, G., Rodríguez‐Violante, M., Cervantes‐Arriaga, A., Navarro-Roa, C., Ricardo-Garcell, J., Rodríguez-Camacho, M. A., & Solís‐Vivanco, R. (2020) · Clinical Neurophysiology · doi:10.1016/j.clinph.2020.11.035 · Cited by 19
Oh, Y.-S., Yoo, S.-W., Lyoo, C. H., Yoo, J.-Y., Yoon, H., Ha, S., Lee, K.-S., & Kim, J.-S. (2021) · Journal of Parkinson s Disease · doi:10.3233/jpd-202496 · Cited by 19
Nervonic acid amends motor disorder in a mouse model of Parkinson’s disease
Hu, D., Cui, Y., & Zhang, J. (2021) · Translational Neuroscience · doi:10.1515/tnsci-2020-0171 · Cited by 18
RetractedInorganic Nanomaterial for Biomedical Imaging of Brain Diseases
Du, W., Zhou, L., Zhang, Q., Liu, X., Wei, X., & Li, Y. (2021) · Molecules · doi:10.3390/molecules26237340 · Cited by 18
Xiao, Y., Ou, R., Yang, T., Liu, K., Wei, Q., Hou, Y., Zhang, L., Lin, J., & Shang, H. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2021.749471 · Cited by 18
Targeting phosphodiesterase 4 as a therapeutic strategy for cognitive improvement
Wei, X., Yu, G., Shen, H., Luo, Y., Shang, T., Shen, R., Xi, M., & Sun, H. (2022) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2022.106278 · Cited by 17
Alves, C. L., Cury, R. G., Roster, K. I. O., Pineda, A. M., Rodrigues, F. A., Thielemann, C., & Ciba, M. (2022) · PLoS ONE · doi:10.1371/journal.pone.0277257 · Cited by 17
Protective Role of Electroacupuncture Against Cognitive Impairment in Neurological Diseases
Xin, Y., Zhou, S., Chu, T., Zhou, Y., & Xu, A. (2024) · Current Neuropharmacology · doi:10.2174/1570159x22999240209102116 · Cited by 18
Parkinson’s disease psychosis associated with accelerated multidomain cognitive decline
Pisani, S., Gosse, L., Aarsland, D., Chaudhuri, К. R., Ballard, C. G., Ffytche, D. H., Velayudhan, L., & Bhattacharyya, S. (2024) · BMJ Mental Health · doi:10.1136/bmjment-2024-301062 · Cited by 17
Self-citationEarly Cognitive Impairment Behind Nigrostriatal Circuit Neurotoxicity: Are Astrocytes Involved?
Herrera, M. L., Deza-Ponzio, R., Ghersi, M., de la Villarmois, E. A., Virgolini, M. B., Pérez, M. F., Molina, V. A., Bellini, M. J., & Hereñú, C. B. (2020) · ASN NEURO · doi:10.1177/1759091420925977 · Cited by 17
Event-related oscillations differentiate between cognitive, motor and visual impairments
Rosenblum, Y., Shiner, T., Bregman, N., Fahoum, F., Giladi, N., Maidan, I., & Mirelman, A. (2022) · Journal of Neurology · doi:10.1007/s00415-021-10953-4 · Cited by 17
Frailty and cognitive impairment in Parkinson’s disease: a systematic review
Sousa-Fraguas, M. C., Fuentes, G. R., & Conejo, N. M. (2022) · Neurological Sciences · doi:10.1007/s10072-022-06347-7 · Cited by 19
Assessing Genetic Overlap Between Platelet Parameters and Neurodegenerative Disorders
Tirozzi, A., Izzi, B., Noro, F., Marotta, A., Gianfagna, F., Hoylaerts, M., Cerletti, C., Donati, M. B., de Gaetano, G., Iacoviello, L., et al. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.02127 · Cited by 17
Metadata
- Authors
- Aarsland, D., Creese, B., Politis, M., Chaudhuri, K. R., ffytche, D. H., Weintraub, D., & Ballard, C.
- Affiliations
- King's College London (GB)
- Corresponding author
- Aarsland, Dag
- Venue
- Nature Reviews Neurology
- Published
- 2017-03-03
- Volume
- 13
- Issue
- 4
- Pages
- 217-231
- ISSN
- 1759-4758 (ISSN-L)
- 1759-4766
- PMC
- PMC5643027
- OpenAlex
- W2593272776
- Cited by
- 1,027
- References
- 216
- Citations by year
- 2026: 102 · 2025: 99 · 2024: 138 · 2023: 104 · 2022: 105 · 2021: 171 · 2020: 116 · 2019: 89 · 2018: 68 · 2017: 33
- FWCI
- 11.11
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Reviews Neurology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Open Research Exeter (University of Exeter) (acceptedVersion)
- Figshare (submittedVersion)
- Research Portal (King's College London) (submittedVersion, other-oa)
- Funders
- South London and Maudsley NHS Foundation Trust
- National Institute for Health and Care Research
- King's College London
- Institute of Psychiatry, Psychology and Neuroscience, King’s College London
- National Institute of Neurological Disorders and Stroke (P50NS053488)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Neurology › Neurological diseases and metabolism
- Keywords
- Parkinson's disease, cognitive decline, Parkinson's disease dementia, mild cognitive impairment, cerebrospinal fluid biomarkers, amyloid-beta 42, Lewy body pathology, APOE ε4, GBA mutations, cognitive training, nootropic drugs
- MeSH terms
- Dementia, Humans, Parkinson Disease, Cognitive Dysfunction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
